[1]
Ömer Kutlu, E. Karaarslan, N. Karaosmanoğlu, and H. M. Ekşioğlu, “Evaluation of omalizumab at certain time intervals in patients with chronic spontaneous idiopathic urticaria”, Int J Sci Rep, vol. 5, no. 12, pp. 351–354, Nov. 2019.